Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Grant revenue	$ 12,500	$ 122,686
Operating expenses
Research and development	1,793,145	472,613
Salaries and benefits	495,518	205,828
General and administrative	603,632	219,070
Total operating expenses	2,892,295	897,511
Operating loss	(2,879,795)	(774,825)
Other income (expenses):
Investment income	372	98
Loan forgiveness	74,268
Gain on investments	105,919	13,494
Total other income	180,559	13,592
Loss before income taxes	(2,699,236)	(761,233)
Income tax (expense) benefit	987,353	(31,907)
Net loss	(1,711,883)	(793,140)
Preferred stock dividend	(285,567)	(269,379)
Net loss attributable to common stockholders	$ (1,997,450)	$ (1,062,519)
Net loss per common share, basic and diluted	$ (0.34)	$ (0.18)
Weighted average common shares outstanding, basic and diluted	5,881,898	5,881,898